Taro Recalls TopCare Clotrimazole Cream Due to Impurity
Taro Pharmaceuticals is recalling TopCare Clotrimazole Cream because an unknown degradation impurity was detected slightly above the specification limit.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) in the absence of reported injuries or more severe hazards.
Plain-English summary
Taro Pharmaceuticals U.S.A., Inc. is recalling TopCare (Clotrimazole) Cream USP, 1%, Antifungal. The recall involves a specific lot of the product, identified as Lot # D867331277 with an expiration date of March 2021. The product is distributed by Topco Associates LLC in Elk Grove Village, IL, and was distributed nationwide in the USA and Canada.
The recall was initiated because an unknown degradation impurity was detected slightly above the specification limit in the Clotrimazole Cream USP 1%. This is a Class II recall, which indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers who have purchased this specific lot of TopCare Clotrimazole Cream should stop using it and contact Taro Pharmaceuticals or their healthcare provider for further instructions. The product is an over-the-counter antifungal cream used for athlete's foot.
The recalled product
- Product
- TOPCARE (CLOTRIMAZOLE)
- Brand
- TOPCARE
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Category
- Drug — OTC Antifungal
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: D867331277
- Exp Mar 2021 70
- 200 63
- 252
UPCs (1)
- 036800495692
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Taro Pharmaceuticals U.S.A., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Taro Pharmaceuticals U.S.A., Inc.
See all →- ModerateHydrocortisone & Acetic Acid Otic Solution Recalled for Potency and Impurity Failures
FDA (Drugs) · 2024-08-21
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- SevereClobetasol Propionate Ointment Recalled for Microbial Contamination
FDA (Drugs) · 2022-01-19
- HighTaro Recalls Nortriptyline Hydrochloride Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2021-02-10
- ModerateTaro Recalls Rite Aid Clotrimazole Cream Due to Impurity
FDA (Drugs) · 2020-12-23
Same hazard · impurity
See all →- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
Similar recalls
- ModerateTaro Recalls Clobetasol Propionate Cream Due to Content Uniformity Failure
FDA (Drugs) · 2018-02-07
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- ModerateClotrimazole and Betamethasone Topical Cream Recalled for Failed Potency Specifications
FDA (Drugs) · 2022-04-06
- LowTaro Recalls Topicort Topical Spray Due to Impurity Test Failures
FDA (Drugs) · 2015-09-02
- ModerateClindamycin topical solution recalled after failing impurity and assay specifications
FDA (Drugs) · 2026-01-21
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Specifications
FDA (Drugs) · 2026-10-14